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Abstract
Objective: Dementia is a common and feared aspect of Parkinson’s disease but
there are no robust predictors of cognitive outcome. Visuoperceptual deficits
are linked to risk of dementia in Parkinson’s disease but whether they predict
cognitive change is not known, and the neural substrates of visuoperceptual
dysfunction in Parkinson’s have not yet been identified. Methods: We com-
pared patients with Parkinson’s disease and unaffected controls who underwent
BOLD fMRI while performing our previously validated visuoperceptual task
and tested how functional connectivity between task-specific regions and the
rest of the brain differed between patients who performed well and poorly in
the task. Results: We show that task performance at baseline predicts change in
cognition in Parkinson’s disease after 1 year. Our task-based fMRI study
showed that the performance in this task is associated with activity in the pos-
terior cingulate cortex/precuneus. We found that functional connectivity
between this region and dorsomedial prefrontal cortex was reduced in poor
performers compared with good performers of this task. Interpretation: Our
findings suggest that functional connectivity is reduced between posterior and
anterior hubs of the default mode network in Parkinson’s patients who are
likely to progress to worsening cognitive dysfunction. Our work implicates pos-
terior default mode nodes and their connections as key brain regions in early
stages of dementia in Parkinson’s disease.
Introduction
Dementia is one of the most debilitating aspects of Parkin-
son’s disease, affecting 50% of people within 10 years of
diagnosis, with wide variability in timing and severity.1
Being able to determine the anatomical basis of the earliest
stages of Parkinson’s dementia is a priority to enrich popu-
lations for clinical trials of treatments that slow progression
of Parkinson’s dementia. Identifying neuroanatomical sub-
strates of Parkinson’s dementia will also provide important
insights into the mechanistic basis of selective vulnerability.
The anatomical substrates of the earliest stages of
Parkinson’s dementia are poorly defined and to date,
neuroimaging predictors of Parkinson’s dementia have
been elusive. Structural measurements of gray matter
atrophy using conventional techniques show inconsistent
patterns,2–4 most likely because cell death, indexed by
gray matter atrophy, is a late event in Parkinson’s
dementia.5 Functional changes linked with tests predic-
tive of cognitive dysfunction may be better suited to
detect the earliest signs of cognitive involvement in
Parkinson’s disease.6
Recent evidence suggests that Parkinson’s patients with
visual processing deficits are at higher risk of dementia.
In population studies, patients making errors copying
intersecting pentagons are at double the risk of dementia
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at follow-up.1 Patients with occipital hypometabolism at
baseline show higher rates of converting to Parkinson’s
dementia,7 and in postmortem studies, Parkinson’s
patients with an occipital distribution of Lewy-related
pathology developed more rapid dementia and died
sooner.8 One event-related fMRI study examined brain
activity during visuoperceptual tasks and showed differ-
ences in brain activity in superior parietal regions, in the
absence of differences in task accuracy,9 but how this
relates to development of Parkinson’s dementia has not
been shown.
Emerging studies of functional connectivity in cogni-
tively intact Parkinson’s suggest that changes in the
default mode network (DMN) may be linked to cognitive
performance in non-demented Parkinson’s disease.10,11
However, how this relates to development of dementia in
Parkinson’s disease is not known.
We recently developed a sensitive test of visuopercep-
tual processing, and showed that the performance in this
test is related to an independent risk score for Parkin-
son’s dementia.12 The neural correlates of performing this
visuoperceptual task are not known, and whether this task
can predict Parkinson’s dementia has not yet been shown.
Here, we measured BOLD signals while people with
Parkinson’s and age-matched controls performed our
visuoperceptual task. We hypothesized that (1) People
performing worse in this task would show worse cognitive
performance after 1 year. (2) Higher-order visual process-
ing regions would be implicated in this task in unaffected
controls. (3) These regions would show reduced activity
in Parkinson’s patients that performed poorly on our
task, compared with those that perform well. (4) Task-
dependent functional connectivity would be reduced in
poorly performing Parkinson’s patients compared with
high performers.
Methods and Materials
Participants
Twenty people with Parkinson’s disease were recruited
from our UK center between September 2015 and May
2016. Inclusion criteria were early to mid-stage Parkin-
son’s disease (Queen Square Brain Bank Criteria). Exclu-
sion criteria were confounding neurological disorders,
dementia, and metallic implants considered unsafe for
MRI scanning (e.g., permanent pacemakers). Participants
continued their usual therapy and Levodopa equivalent
daily dose (LEDD) was calculated.13 One participant
missed an excessive number of trials (>40% in each
experimental run) and was excluded. The data reported
here therefore include 19 people with Parkinson’s disease.
Ten age-matched controls were recruited from university
databases and unaffected spouses. All participants gave
written informed consent and the study was approved by
the Queen Square Research Ethics Committee.
Clinical evaluation
Severity of symptoms was assessed using the MDS-
UPDRS. Cognition was assessed using the Montreal Cog-
nitive Assessment (MoCA), at baseline and at follow-up
(mean 12.6 months, range 8–17 months), in 22 partici-
pants (15 with Parkinson’s). Change in cognitive perfor-
mance was quantified as the difference between follow-up
and baseline scores. Visual acuity was assessed using a 6-
m Snellen chart and converted to decimal acuity.14 Con-
trast sensitivity was measured using a Pelli-Robson chart
(SSV-281-PC) (http://www.sussex-vision.co.uk) (Table 1).
Experimental task
Stimuli were generated as previously described.12 Briefly,
images of 1000 cats and dogs from an online database
(http://www.kaggle.com) were cropped and converted to
grayscale. Fourier transforms of each image were com-
puted to produce magnitude and phase images. The phase
matrix of each cat or dog image was skewed along the x-
axis by a variable amount of skew (four levels: 0, 1.4, 2.2,
and 2.8 a.u.). This was combined with a proportion of
white noise and recombined with the average magnitude
matrix of the series. Resulting images had identical spatial
frequency with four levels of skew. Skew levels were cho-
sen based on psychophysical thresholds measured previ-
ously, to include no skew, two moderate levels, that
equated to median levels of tolerated skew in people with
Parkinson’s and controls, respectively, and extreme skew
not tolerated by any participants.12
Control images were generated in the same way, but
instead of an affine transformation, a varying proportion
of visual noise was added (four levels: 0, 0.5, 0.8, and
1.2 a.u.). The amount of noise varied according to the
following formula:
Test image ¼ Image  ð1 Contrast levelÞ
þ ðNoise matrix  Contrast levelÞ
Stimuli were presented in MATLAB 2014a (MathWorks
Inc, Natick, MA) using Cogent 2000 (http://www.vislab.
ucl.ac.uk/cogent_2000.php) onto an Epson EH-TW5900/
59100 projector (screen width 26 cm, screen height
21 cm, at approximately 78 cm viewing distance). Partici-
pants viewed the screen through a mirror attached to the
head coil. Image widths subtended 32.5 9 8.7 degrees
visual angle with mean luminance 6.48 cd/m2.
All participants underwent practice sessions outside the
scanner, immediately prior to image acquisition to ensure
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familiarity with the task. Each trial consisted of a fixation
cross for 400 msec, followed by the skewed or noisy
image for 280 msec (Fig. 1). Short presentation times
were used to avoid confounds from eye movements. Par-
ticipants responded using a fiber-optic response pad, with
side of response pseudorandomized at the start of every
run, but kept constant for the run duration. This avoided
a laterality bias for responses and minimized confusion
between trials. Response time window was 1800 msec.
Intertrial interval was jittered with mean 450 msec. There
were six experimental task runs, each lasting approxi-
mately 6 min: four runs of skewed images and two runs
of noisy images, with order of skewed and noisy runs
randomized for each participant.
Imaging acquisition
Participants were scanned (at baseline) in a Siemens Trio
3-Tesla MRI scanner with 32-channel head coil.
Functional data were acquired with a 2D gradient-echo
planar sequence: 48 transverse slices, slice thick-
ness = 2.5 mm, gap between slices = 0.5 mm, repetition
time TR = 3.36 sec, TE 30 msec, and inplane resolution
3.0 9 3.0 9 3.0 m. The first five volumes were discarded
to allow T1 equilibration.
A B0 field map was obtained after functional data
acquisition: short TE = 10 msec; long TE = 12.46 msec;
polarity of phase-encode blips = 1; total EPI readout
time = 37 msec, ascending slice order. Heart rate and res-
piration were monitored using an MRI-compatible pulse
oximeter (Nonin 8600 FO) and pneumatic belt,15 and
recorded, along with scanner pulses via a Cambridge Elec-
tronic Devices Micro 1401 Mk11 connected to a laptop
running Spike2 version 6. A T1-weighted structural scan
was acquired for each participant and used for normaliza-
tion of functional data (TR = 7.92 msec, TE = 2.45 msec,
T1 = 910 msec, flip angle a = 16°, 176 = slices,
1 9 1 9 1 mm voxels, FIV = 256 9 240 mm216).
Table 1. Demographics of participants.
Controls
Mean (SD)
PD
Mean (SD) T (or v2) (df) P
n 10 19 – –
Age (SD), (range) 64.8 (11.2), (45–78) 64.2 (6.1), (55–72) 0.15 (11.9) 0.88
M/F 4/6 10/9 0.4 (1) 0.52
Disease duration PD (years) NA 5.2 (3.5) – –
H&Y NA 1.4 (0.60) – –
MDS-UPDRS 4.1 (4.3) 27.9 (11.7) 7.8 (25) <0.0001*
LEDD NA 643.0 (372) – –
Best visual acuity 1.06 (0.2) 1.01 (0.2) 0.56 (20) 0.58
Contrast sensitivity (both eyes)1 1.82 (0.14) 1.82 (0.19) –0.11 (21) 0.91
MOCA (baseline) 28.9 (1.6) 28.9 (1.2) 0.009 (14.5) 0.99
MOCA (follow-up) (n) 28.4 (1.5) (7) 28.3 (1.5) (9) 0.13 (13) 0.90
Time to MOCA follow-up (Months) 12.4 (3.8) 12.6 (2.9) 0.15 (9) 0.89
High performers
with Parkinson’s
Low performers
with Parkinson’s T (or v2) (df) P
n 11 8
Age 62.4 (5.9), (55–70) 66.6 (5.9), (56–72) 1.5 (15) 0.15
M/F 3/8 7/1 6.7 (1) 0.0094*
Disease duration (years) 3.8 (3.3) 7.2 (3.2) 2.3 (16) 0.039*
H&Y 1.1 (0.3) 1.8 (0.7) 2.5 (9) 0.036*
MDS-UPDRS 22.6 (9.4) 35.1 (11.1) 2.6 (14) 0.023*
LEDD 488 (259) 857 (430) 2.1 (11) 0.055
Best visual acuity 1.05 (0.2) 0.96 (0.2) 0.91 (15) 0.38
Contrast sensitivity (both eyes) 1.87 (0.16) 1.76 (0.22) 1.2 (12) 0.27
MOCA (baseline) 28.7 (1.6) 29.1 (0.4) 0.82 (11) 0.43
MOCA (follow-up) (n) 28.7 (1.5) (9) 27.8 (1.5) (6) 1.6 (11) 0.31
Time to MOCA follow-up (Months) 11.9 (2.7) 13.0 (3.6) 0.56 (5) 0.60
Df, degrees of freedom; H&Y, Hoehn and Yahr; LEDD, Levodopa equivalent dose; MDS-UPDRS, movement disorder society unified Parkinson’s dis-
ease rating scale; MOCA, Montreal cognitive assessment; PD, Parkinson’s disease; SD, standard deviation.
1Data from one control participant not available.
*P < 0.05.
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Behavioral analyses
For each level of skew or noise, we calculated d prime
(d0), using the following equation:
d0 ¼ zðHÞ  zðFAÞ
where z indicated inverse of the cumulative normal distri-
bution, H the hit rate, and FA the false alarm rate.
Extreme values were corrected by dividing 0.5 by number
of trials at that level.17 We checked the number of missed
trials per run, and excluded runs where missed trials
exceeded 40% (1 participant, 1 run). As described above,
one more participant was excluded from analyses, due to
excessive missed trials.
To categorize participants as low or high performing,
we analyzed the performance at the second skew level for
all odd trials. Participants with d0 ≥ 1 were considered
high performers. For subsequent behavioral analyses at
that level, we only included even trials, to avoid resam-
pling the same dataset. Between-group differences in
response times, performance, and clinical and demo-
graphic measures were assessed using ANOVAs. Post hoc
t-tests were used to compare the groups. Between-group
differences in categorical variables were assessed using
Chi-squared contingency tests.
Imaging analysis
Data analysis used SPM12(WTCN; http://www.fil.ion.uc
l.ac.uk/spm) and involved standard methods (realignment
and unwarping, normalization) using parameters esti-
mated from normalization of segmented structural images
Figure 1. Experimental task. (A) Each trial started with a plain gray screen with a central fixation cross for 400 msec. On each trial, a different
image of a cat or dog was shown that was skewed by a variable amount (four levels of skew between 0 a.u. and 2.8 a.u., defined in pilot
sessions), order pseudorandomized. The image was shown for 280 msec. This was followed up by a screen with the letters C and D, indicating
cat and dog. Participants indicated whether they had seen a cat or a dog by pressing a key on a response pad whilst inside the scanner. (B)
Control trials with noisy images were identical in structure, but increasing amounts of visual noise were added (four levels of noise: between 0
and 1.2 a.u., defined in pilot sessions).
ª 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. 905
R. S Weil et al. Neural Correlates of Early Parkinson’s Dementia
that were coregistered to EPIs and smoothing with an 8-
mm isotropic Gaussian). We performed statistical infer-
ences using the generalized linear model (GLM), imple-
mented in SPM12. Events were characterized by stick
functions at time of onset convolved with the canonical
hemodynamic response function to provide regressors for
the GLM. Presentation of images was taken as onset
times. Nine onset types were modeled: eight for each level
of skewed (0, 1.4, 2.2, and 2.8 a.u.) or noisy image (0,
0.5, 0.8, and 1.2 a.u.), one for missed trials.
The six realignment parameters estimated during pre-
processing were included as estimates of movement and
cardiac and respiratory contributions to the fMRI noise
were modeled.18,19 Altogether the full physiological noise
model yielded a set of 20 regressors that were included in
the GLM for each block. A block-specific mean was also
included in the GLM.
Statistical inference was at the random effects level. Maps
of contrasts of parameter estimates from the single-subject
GLMs formed the raw data for inference in a second-level
analysis where subjects were treated as random effects. Sec-
ond-level analysis was initially restricted to control partici-
pants, to determine regions maximally involved in
conditions of interest during normal visual processing.
We extracted parameter estimates within the whole
main cluster for high and low performers for each of the
eight simple effects (four levels of difficulty for skew and
four levels of difficulty for the noise task). We hypothe-
sized that high performers would show parameter esti-
mates similar to those seen in unaffected controls,
whereas low performers would show differences in the
pattern of parameter estimates.
Psychophysiological interactions
We reasoned that regions showing differences in task-spe-
cific functional activity would relate to well-defined brain
networks. Consequently, we examined functional connec-
tivity between the posterior cingulate cortex (PCC)/pre-
cuneus and the rest of the brain during the performance
of the visuoperceptual task using a psychophysiological
interaction (PPI) analysis.20,21 We set up a GLM with
regressors capturing the physiological effect (time series
for an 8-mm sphere centered on peak voxel of the PCC/
precuneus cluster [3, 64, 19] derived from the whole
brain analysis in unaffected participants), the psychologi-
cal contrast of interest, and the psychophysiological inter-
action term (i.e., physiological effect 9 psychological
contrast of interest). The GLM included six motion
parameters and 20 cardiac and respiratory regressors to
correct for these sources of noise. These formed the new
raw data for inference in a second-level analysis. At the
second level, we compared functional connectivity
between the PCC/precuneus and the rest of the brain
between high- and low-performing participants with
Parkinson’s disease. As this analysis was considered
exploratory, we accepted a lower threshold of significance,
P < 0.001 uncorrected.
Results
Demographics
Twenty Parkinson’s patients and 10 unaffected controls
completed the study. One participant with Parkinson’s
was removed due to excessive missed trials (see Methods),
leaving 19 Parkinson’s patients and 10 controls in the
analyses here. Participants were well-matched for age and
gender. The mean age of participants with Parkinson’s
disease was 64.2 (6.1) years, and mean age of controls
was 64.8 (11.2) years (Table 1). The mean disease dura-
tion was 5.2  3.5 years, and the mean Hoehn and Yahr
(H&Y) score was 1.4 (0.6). There were no significant
differences between the groups in measures of cognition,
visual acuity, or contrast sensitivity (Table 1), and none
of our participants had dementia.
Behavioral performance
As expected, all participants’ performance worsened as
images became more skewed and more noisy, with a main
effect of difficulty for both the skew (F(3,81) = 88.2,
P < 0.0001) and noise task (F(3,81) = 101.1, P < 0.0001).
There was no main effect of Parkinson’s disease, or inter-
action between the presence of Parkinson’s disease and
the level of difficulty for the skewed or noise tasks.
We used performance measured by d0 ≥ 1 at the sec-
ond level of skew (1.4 a.u.) to divide Parkinson’s patients
into high and low performers. This level was used as our
previous work12 showed this was the mean threshold of
tolerance in Parkinson’s disease. This generated two
groups: 8 low performers and 11 high performers. These
groups did not differ in cognitive performance or visual
acuity and contrast sensitivity. However, there was a sig-
nificantly higher proportion of men in the poor-perform-
ing group (7/8, compared with 3/11, P = 0.009). Disease
duration was higher in the poor-performing group, as
were measures related to disease severity including H&Y,
UPDRS, and levodopa dose (Table 1).
The performance in the skew task showed a main effect
of group (high vs. low performers): F(1,17) = 35.5,
P < 0.0001); a main effect of difficulty: F(3,51) = 58.1,
P < 0.0001; but there was no interaction between the
group and amount of skew: F(3,51) = 2.2, P = 0.10)
(Table 2). This result was not surprising, as we had
divided participants into high and low performers based
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on performance in this task. This division was performed
for later analysis of the fMRI data based on the perfor-
mance level. We include it here so that demographics and
range of performance in the two groups can be seen.
For the visual noise task, we found a main effect of group
(high vs. low performers): F(1,17) = 24.8, P = 0.00011;
main effect of difficulty: F(1,55) = 119.6, P < 0.0001; but
the interaction between the group and amount of noise did
not reach significance: F(1,55) = 2.3, P = 0.14).
A three-way ANOVA of the group (three levels: con-
trols, high, and low performers), difficulty (four levels),
and task (two levels: skew vs. noise) showed a main effect
of group F(1,17) = 44.2, P < 0.001; main effect of diffi-
culty, F(3,119) = 137.4, P < 0.0001; and main effect of
task type, F(1,119) = 33.1, P < 0.0001. There was an
interaction between the group and difficulty, F
(1,17) = 4.6, P = 0.0042; trend to interaction between the
group and task type, F(1,119) = 3.3, P = 0.070; an inter-
action between difficulty and task type, F(3,119) = 4.1,
P = 0.0084. However, there was no interaction between
the group, task, and difficulty.
The interaction of difficulty and task and trend toward
the group (high performers vs. low performers) and task
(skew vs. noise) suggests some specificity to type of task.
Planned post hoc t-tests show this is driven by difference
between high and low Parkinson’s performers in higher
levels of difficulty in the skew task, but not in the visual
noise task (Table 2).
Visual performance predicts cognitive
change after 1 year
We found a strong association between performance in
the skew task and change in cognitive performance after
1 year in Parkinson’s patients, R2=0.51, F(1,13) = 13.6,
P = 0.0027 (Fig. 2). This effect was also seen when we
included unaffected participants (R2 = 0.23, F
(1,20) = 6.1, P = 0.023), although with a lower value for
R2, suggesting this relationship is more specific to predict
cognitive change in Parkinson’s disease. We also found a
strong association between performance in the noise task
and change in cognitive performance over time in Parkin-
son’s patients, R2 = 0.55, F(1,13) = 15.9, P = 0.0016. This
effect was also seen when we included unaffected partici-
pants (R2=0.33, F(1,20) = 9.7, P = 0.0054). This relation-
ship was not driven by subtle differences in baseline
MoCA, as there was no association between baseline
MoCA and change in MoCA over time (R2 = 0.07,
P = 0.34). Neither was there a relationship between dose
of levodopa and performance in the skew task (R2 = 0.10,
Table 2. Performance in skew and visual noise tasks.
Level
Performance in
controls d0
PD high
performers d0
PD low
performers d0
T (df) (controls
vs. PD high) P
T (df) (controls
vs. PD low) P
T (df) (PD high
versus low) P
Skew task
Skew 1 2.12 (0.37) 2.30 (0.22) 1.51 (0.46) 1.4 (15) 0.17 3.0 (13) 0.010* 4.48 (9) 0.0014*
Skew 2 1.60 (0.56) 1.52 (0.31) 0.59 (0.64) 0.39 (14) 0.70 3.51 (14) 0.0035* 3.8 (9) 0.0039*
Skew 3 0.70 (0.5) 0.82 (0.50) 0.33 (0.40) 0.56 (19) 0.58 1.7 (16) 0.10 2.4 (17) 0.028*
Skew 4 0.61 (0.41) 0.65 (0.38) 0.29 (0.24) 0.22 (18) 0.82 2.0 (15) 0.058* 2.5 (17) 0.022*
Visual noise task
Noise 1 1.94 (0.36) 2.07 (0.42) 1.56 (0.46) 0.74 (19) 0.47 1.9 (13) 0.073 2.5 (14) 0.025*
Noise 2 1.22 (0.55) 1.24 (0.51) 0.44 (0.52) 0.09 (18) 0.94 3.1 (16) 0.0072* 3.4 (15) 0.0042*
Noise 3 0.082 (0.57) 0.056 (0.27) 0.18 (0.66) 0.70 (13) 0.50 0.89 (14) 0.39 0.50 (9) 0.63
Noise 4 0.013 (0.53) 0.067 (0.33) 0.066 (0.31) 0.41 (15) 0.69 0.27 (15) 0.79 0.90 (16) 0.38
Performance at each level of skew and each level of the blur task, in each of the three groups, measured using d prime: unaffected controls, and
Parkinson’s participants in the high- and low-performance groups. Note that groups were defined by performance at the second skew level (Skew
2), using alternate (odd-numbered) trials. Data at the second level of skew shown here are therefore for even trials.
Df, degrees of freedom; PD, Parkinson’s disease; vs, versus.
*P < 0.05.
Figure 2. Relationship between baseline performance in the skew
task and change in MoCA after 12-month follow-up.
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P = 0.19) or dose of levodopa and change in cognition
over time (R2 = 0.09, P = 0.18).
Neural correlates of skew image detection
Whole brain analysis of main effect of task (skew vs.
noisy image) in unaffected controls did not reveal signifi-
cant regions of activity at family-wise error corrected
levels. The main effect of difficulty revealed BOLD activa-
tions associated with higher difficulty in right insula, peak
MNI coordinates [30, 23, 1], k = 50, Z = 3.88, P = 0.02
FWE-corrected at cluster level, with a second peak within
this at [48, 17, 1] Z = 3.29 (Fig. 3A).
The interaction between task and increasing difficulty
across all four levels of difficulty revealed BOLD differ-
ences within a region in medial parietal lobe correspond-
ing to the PCC/precuneus, peak MNI coordinates [3,
64, 19], P = 0.001 FWE-corrected at cluster level,
Z = 4.38, k = 124. Within this cluster, two other peaks
were found: in the PCC/precuneus [12, 58, 13],
Z = 4.30, and at [9, 58, 25], Z = 4.25 (Fig. 3B). No
other peaks survived correction for multiple comparisons.
We next inspected parameter estimates for each condi-
tion (four levels each for skew and noise) for each
participant group (controls, high- and low-performing
Parkinson’s patients) within the main cluster at the PCC/
precuneus. This revealed a main effect of task (F
(1,182) = 29.5, P < 0.0001). There was a strong interac-
tion between the participant group (controls, high vs. low
performers with Parkinson’s disease) and task (skew vs.
visual noise)) (F(2,182) = 12.3, P < 0.0001), but no inter-
action between the group and difficulty or between the
group, task, and difficulty. We also examined parameter
estimates for Parkinson’s participants only. This also
revealed an interaction between the participant group
(high vs. low performers with Parkinson’s) and task (F
(1,119) = 19.3, P < 0.0001) and an interaction between
the group and difficulty (F(3,119) = 3.0, P = 0.033, but
no interaction between group, task, and difficulty.
Whole brain analysis of this interaction for each of the
Parkinson’s groups (high and low performers) did not
reveal significant regions of activation, even at lower
thresholds. However, when we compared brain activity
between these two groups (high > low performers), for the
interaction of skew/noise and difficulty, this revealed a
cluster in left parietal lobe, close to the angular gyrus [39,
67, 49], P = 0.045 FWE-corrected at cluster level,
Z = 4.27, k = 54, with a subpeak in the same cluster [35,
76, 43], Z = 4.23 and a further peak in the middle frontal
gyrus [27, 44, 13], P = 0.037 FWE-corrected, Z = 3.98,
k = 57 (Fig. 4A and B). These effects were not caused by
artifacts linked with head movements. We examined head
movements during scanning for each axis of movement (x,
y, z, and pitch, roll and yaw) and did not see any differ-
ences in scan-to-scan head movements between high- and
low-performing patients with PD (see Table 3).
Figure 3. Neural correlates of skew performance. (A) SPM showing
main effect of increasing difficulty across tasks in unaffected
individuals, overlaid on the mean T1 image of all participants. Threshold
for display < 0.001 uncorrected. (B) SPM showing the interaction of
skew task and increasing difficulty in unaffected individuals, overlaid on
the mean T1 image of all participants. Threshold for display < 0.001
uncorrected. Scale bars represent T value of coordinates.
Figure 4. Neural correlates of skew performance in high- versus low-
performing Parkinson’s patients. SPM showing greater BOLD activity
in high- versus low-performing Parkinson’s patients in the left parietal
(A) and prefrontal regions (B). Threshold for display < 0.001
uncorrected, with cluster level correction applied. Scale bar represents
T value of coordinates.
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Differences in functional connectivity in
low- versus high-performing Parkinson’s
patients
Our behavioral finding of a positive association between
performance in the skew task and change in cognition over
time motivated us to test whether variation in skew detec-
tion is mediated via differences in functional connectivity
between task-specific areas and other regions across the
whole brain. We used a psychophysiological interaction
analysis between the PCC/precuneus and the rest of the
whole brain to examine this. Our connectivity analysis
showed that activity related to the skew task correlated posi-
tively with functional coupling between the PCC/precuneus
and dorsomedial prefrontal cortex (dmPFC) in high-per-
forming, but not low-performing Parkinson’s patients, with
a peak in the dmPFC, BA10 (Fig. 5, peak MNI coordinates
[9, 59, 10], k = 20, Z = 3.67, P < 0.001, uncorrected).
This suggests that patients with Parkinson’s disease with the
earliest stages of cognitive involvement may show reduced
functional connectivity between posterior and anterior
nodes of the default mode network.
Discussion
We aimed to identify the neural correlates of the early
stages of cognitive change in Parkinson’s disease. We show
that performance in a visuoperceptual skew task correlates
with change in cognition over time. We show that in
unaffected individuals, the visuoperceptual skew task is
mediated via activity in the PCC/precuneus, and that in
people with Parkinson’s who are worse at this task, activ-
ity in this region is reduced during task performance. Our
functional connectivity analysis revealed that neural activ-
ity during this task correlated positively with the dmPFC,
an anterior node of the default mode network that is
beginning to be implicated in Parkinson’s dementia.11
Links to Parkinson’s dementia
The importance of visuoperceptual deficits as an early
indicator of Parkinson’s dementia is evident from popula-
tion1,22 and FDG-PET studies.7 Postmortem data show
that occipital involvement is related to more rapid pro-
gression to Parkinson’s dementia.8 Our previous behav-
ioral work showed that visuoperceptual deficits are linked
to poorer cognitive performance at baseline and to algo-
rithmic scores predicting cognitive change.12
The neuroanatomical substrates of early cognitive changes
in Parkinson’s have not been previously described. Volumet-
ric studies of gray matter change in Parkinson’s do not
show consistent regional thinning associated with cognitive
change.4,6,23,24 Recent cross-sectional connectivity analyses in
non-demented Parkinson’s disease show changes in occipital
connections are linked to poorer cognitive performance.25
Our work now shows that change in the PCC/precuneus
activity may be an important early indicator of future cogni-
tive involvement in Parkinson’s disease.
Role of DMN in Parkinson’s dementia
We identified changes in brain activity in the PCC/pre-
cuneus and reduced functional connectivity to the
dmPFC during task performance. These regions form key
nodes in the DMN, one of several brain networks identi-
fied using resting-state fMRI26,27 and thought to be
involved in redirecting activity from internal to external
goal-directed processes.28 Changes in DMN functional
connectivity may be associated with cognitive changes in
Parkinson’s disease. Decreased functional connectivity is
seen within the medial temporal and bilateral inferior
parietal cortex in Parkinson’s compared with controls,
with loss of connectivity correlated with cognitive perfor-
mance.10,11 Similarly, Yao29 found lower functional con-
nectivity within the DMN in Parkinson’s disease,
including the PCC and precuneus. Other studies have
shown similar findings.30–32
Reduced DMN activity may be linked with subtypes of
Parkinson’s at higher risk of dementia. For example,
patients with the akinetic rigid form of Parkinson’s
Table 3. Movement parameters in each dimension for participants at
low risk versus high risk for dementia in Parkinson’s disease.
Axis Low-risk PD High-risk PD T P
X (SD) (mm) 0.051 (0.05) 0.025 (0.02) 1.5 0.18
Y (SD) (mm) 0.049 (0.007) 0.038 (0.02) 1.5 0.17
Z (SD) (mm) 0.16 (0.2) 0.091 (0.05) 1.0 0.34
Roll (SD) (deg) 0.091 (0.04) 0.076 (0.08) 0.57 0.57
Pitch (SD) (deg) 0.056 (0.03) 0.029 (0.02) 2.0 0.074
Yaw (SD) (deg) 0.052 (0.03) 0.031 (0.03) 1.6 0.13
Values are mean scan-to-scan movements in mm or degrees.
Figure 5. Psychophysiological interactions. SPM showing difference
in functional connectivity to seed voxel identified in Figure 3B
between high- and low-performing patients with Parkinson’s disease.
Thresholded at < 0.001 uncorrected for display, with cluster level
correction applied. Scale bar represents T value of coordinates.
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disease show decreased DMN activity than those with the
less severe tremor-predominant form.33 Huang and co-
workers showed these differences in the left IPC and
PCC11 and patients with Parkinson’s with mild cognitive
impairment similarly show reduced DMN activity.34
Deactivation in the DMN is seen in other dementias.
Firbank and colleagues35 showed strong deactivations in
the posterior DMN in Lewy Body and Parkinson’s
Dementias. Reduced DMN functional connectivity is well
described in Alzheimer’s disease.36 These changes are seen
in MCI, prior to onset of Alzheimer’s,37 in prodromal
Alzheimer’s disease38 and in carriers of genetic mutations
linked to Alzheimer’s.39,40 Whether alterations in poste-
rior nodes of the DMN are linked to cognitive deficits
due to a key role in cognitive processing, or represents
selective vulnerability due to high connectivity and meta-
bolic demands is not yet known and whether the DMN is
selectively affected ahead of other brain networks in
Parkinson’s dementia is not yet known and could be
explored in future work.
Limitations and future directions
There are some methodological considerations for this
study. Although our findings survived statistical correc-
tion for multiple comparisons, our study included a rela-
tively small number of subjects. The exploratory
functional connectivity analyses were not corrected for
multiple comparisons and will need to be replicated in
larger cohorts. Not all patients with Parkinson’s disease
were available for follow-up testing, although only a small
proportion were lost to follow-up, and our drop-out rate
of 21% is in line with other data series in similar patient
groups.41–43 Our data include patients with varying dis-
ease duration which may influence performance and/or
neural activity. Future studies could examine larger num-
bers, with a more detailed cognitive battery.
Although we showed some specificity of the skew task
compared to the visual noise task, patients with Parkin-
son’s disease also showed deficits in the visual noise task.
This task probes earlier, lower level visual processing such
as figure-ground segregation. Our finding of deficits at
these stages of visual processing is consistent with several
other studies44–47 showing that visual processing is
affected throughout the visual processing axis in Parkin-
son’s disease. Differences in the specificity for the skewed
task may reflect heterogeneity in these relatively small
patient samples.
It is also not possible to completely rule out that the
effects seen at the PCC/precuneus were driven partly by
residual differences in difficulty between the two tasks,
although the form of the interactions detected there does
not strongly suggest this.
Our participants were studied while on their dopamin-
ergic medication and we did not find any relationship
between levodopa equivalent dose and performance in the
skew task or change in cognition over time. However,
some studies suggest a link between dopamine levels and
DMN activity in Parkinson’s disease.31,48 Future work
could examine visuoperceptual performance at different
stages of the medication cycle.
REM behavior sleep disorder (RBD) has also been
linked to cognitive outcomes in Parkinson’s disease49–52
with a particular link between RBD and visuoperceptual
deficits.53 We did not collect information on RBD in our
participants, and this could be explored in future work.
These findings are of wider importance for patients with
Parkinson’s disease. By implicating posterior brain regions
in the earliest stages of Parkinson’s dementia, these may
now be examined for potential to stratify patients for clin-
ical trials of disease modifying interventions, or as poten-
tial biomarkers of progression. They also point to
fundamental approaches that can be tested in future stud-
ies to identify mechanisms for selective vulnerability of
particular brain regions for Parkinson’s dementia.
In summary, we show that visuoperceptual deficits tested
using a skew task predict worsening cognition in Parkin-
son’s disease; that performance in this task is related to
activity in the PCC/precuneus, with lower levels of activity
in this region in poorer performing participants. Finally,
we show that task-related activity in the PCC/precuneus is
associated with reduced functional connectivity to dmPFC,
both regions implicated in brain networks linked with
Parkinson’s dementia. Our work thus reveals that visuoper-
ceptual deficits, such as those detected with the skew task
are fundamentally linked with critical regions affected at
the earliest stages of Parkinson’s dementia.
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